Research programme: oxazolidinone antibacterials - LegoChem Biosciences

Drug Profile

Research programme: oxazolidinone antibacterials - LegoChem Biosciences

Alternative Names: Arylamidoximes - LegoChem Biosciences; Arylhydroxamates - LegoChem Biosciences; Cyclic amidrazone antibacterials - LegoChem BioSciences; LCB 010062; LCB 010156; LCB 010180; LCB01-0183; LCB01-0339; LCB01-0343; LCB01-0347; LCB01-0647; LCB01-0676; LCB01-0687; LCB01-0699

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator LegoChem Biosciences
  • Class Hydroxamic acids; Oxazolidinones; Oximes
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections; Gram-positive infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in South Korea
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Gram-positive-infections in South Korea
  • 17 Sep 2011 Pharmacodynamics, pharmacokinetics and adverse events data from preclinical studies in Bacterial infections presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2011) ,,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top